Search

everythinglearnresearchcommunity

for

Search:↓

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The S9 fraction with GC-IDMS is effective for measuring 5α-reductase activity.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Intradermal injections might work better for common hair loss than other treatments.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

Androgen-driven traits don't predict prostate cancer recurrence.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Male infertility often lacks thorough investigation, potentially missing reversible causes.

The new method makes finasteride cheaper and easier to produce.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

2-Methoxyestradiol causes cancer cell death by activating specific pathways, but androgens can block this effect.

Testosterone protects female heart cells from stress by activating estrogen receptors.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

A 13-year-old girl's masculine symptoms improved after surgery for a rare adrenal tumor that produced male hormones.

Age-related changes in scalp glands may affect hair health, but sulforaphane might help.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Finasteride helps hair growth by reducing DHT levels.

17b-Estradiol in skin affects hair growth and tumor promotion.

Blocking androgen activity in newborn rats affects body weight and appetite-related hormones differently in males and females.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Women with hair loss have more androgen receptors in certain hair follicles.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.